Allstate Corp Takes $1.44 Million Position in MetLife, Inc. (NYSE:MET)

Allstate Corp acquired a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 17,606 shares of the financial services provider's stock, valued at approximately $1,442,000.

Other large investors also recently bought and sold shares of the company. United Asset Strategies Inc. lifted its stake in MetLife by 1.1% during the fourth quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider's stock worth $895,000 after purchasing an additional 120 shares in the last quarter. Barrett & Company Inc. raised its stake in MetLife by 1.0% in the fourth quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider's stock valued at $978,000 after buying an additional 121 shares in the last quarter. J.W. Cole Advisors Inc. boosted its position in shares of MetLife by 2.1% during the 4th quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider's stock worth $495,000 after acquiring an additional 126 shares in the last quarter. Davis R M Inc. increased its stake in MetLife by 4.2% in the fourth quarter. Davis R M Inc. now owns 3,148 shares of the financial services provider's stock valued at $258,000 after purchasing an additional 127 shares during the last quarter. Finally, Daymark Wealth Partners LLC lifted its position in MetLife by 3.0% in the fourth quarter. Daymark Wealth Partners LLC now owns 5,091 shares of the financial services provider's stock valued at $417,000 after acquiring an additional 149 shares during the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

MetLife Stock Down 6.7 %

MetLife stock traded down $5.49 during midday trading on Thursday, hitting $77.00. 2,433,702 shares of the stock were exchanged, compared to its average volume of 3,282,904. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 1 year low of $67.30 and a 1 year high of $89.05. The company has a 50 day moving average price of $82.98 and a two-hundred day moving average price of $83.01. The firm has a market cap of $52.46 billion, a P/E ratio of 12.88, a P/E/G ratio of 0.65 and a beta of 1.04.

MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, sell-side analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th were paid a dividend of $0.545 per share. The ex-dividend date was Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.83%. MetLife's payout ratio is 36.52%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on MET shares. Piper Sandler upped their price target on shares of MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a research report on Wednesday. Cowen reiterated a "buy" rating on shares of MetLife in a research report on Friday, March 7th. UBS Group increased their price target on shares of MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a research report on Wednesday. Keefe, Bruyette & Woods dropped their price objective on MetLife from $100.00 to $98.00 and set an "outperform" rating for the company in a research report on Wednesday, February 12th. Finally, JPMorgan Chase & Co. cut their price target on MetLife from $88.00 to $86.00 and set an "overweight" rating for the company in a report on Wednesday. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, MetLife presently has a consensus rating of "Moderate Buy" and an average target price of $94.85.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.